✳flâneur — a map of the web's best reading

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease | Diabetologia

link.springer.com · 12,454 words · saved by 1 readers

The Clinical Practice Guidelines propose recommendations for the diagnosis, treatment and follow-up of non-alcoholic fatty liver disease (NAFLD) patients and are the product of a joint effort by the European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO). They update a position statement based on the 2009 EASL Special Conference [1]. The data have been retrieved by an extensive PubMed search up to April 2015. The final statements are graded according to the level of evidence and strength of recommendation, which are adjustable to local regulations and/or team capacities (Table 1) [2]. In particular, screening for NAFLD in the population at risk should be in the context of the available resources, considering the burden for the national healthcare systems and the currently limited effective treatments. The document is intended both for practical use and for advancing the resear

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease Clinical Practice Guidelines Published: 07 April 2016 Volume 59 , pages 1121–1140 ( 2016 ) Cite this article Download PDF Save article View saved research Diabetologia Aims and scope Submit manuscript EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease Download PDF Introduction The Clinical Practice Guidelines propose recommendations for the diagnosis, treatment and follow-up of non-alcoholic fatty liver disease (NAFLD) patients and are the product

Explore this link on the map →

related reading